TABLE 4.
Maculopapular rash developing >3 weeks after starting with the suspected drug |
Prolonged clinical symptoms 2 weeks after discontinuation of the suspected drug |
Fever >38°C |
Liver abnormalities (alanine aminotransferase>100U/L) |
Leucocyte abnormalities |
Leucocytosis (>11 X 109/L) |
Atypical lymphocytosis (>5%) |
Eosinophilia (>1.5 x 109 /L) |
Lymphadenopathy |
Human Herpes 6 reactivation |
The diagnosis is confirmed by the presence of the 7 criteria (typical DHS).